The bridge is already built: management walks investors from today's numbers to a bigger business using only pieces alre
The model's full reasoning — Q4 2023 call → NOWe need to answer YES or NO based on the transcript. The question asks: does management explain where the business is heading over roughly the NEXT YEAR, building that explanation primarily out of SPECIFIC PIECES THAT ARE ALREADY SECURED OR ALREADY IN MOTION — rather than out of market hopes, pipeline, or general demand — such that the results just reported visibly UNDERSTATE the business the company has already locked in? We need to examine the transcript for management's forward-looking statements. The key is whether they name specific secured items that will contribute in the next year, and whether they present the current results as understating the future. From the transcript: - Yehiel Tal discusses the dermal filler with AbbVie. He says: "The dermal filler product candidate, which is our top focus, is now in the clinical phase of development and has the potential to create a paradigm shift..." That's a product in development, not yet commercialized. They have a collaboration with AbbVie, and they received a $10 million milestone payment in 2023. But the future milestones are contingent on development and regulatory approvals. They say: "we are unable to share more information about it." So that's not a secured near-term contribution. - They have a photocurable dermal filler product candidate, but they have granted AbbVie right of first negotiation. That's not secured. - Regenerative breast implants: They are conducting large animal studies. They say: "We look forward to reporting results from this animal studies in the fourth quarter of this year and the first quarter of 2025." That's just reporting results, not commercial contribution. They are still in development. - They have a collaboration with Stratasys for bioprinting. That's a development agreement. - They put gut-on-a-chip on hold. - They mention ESG initiatives. - Financial results: They have cash runway until end of 2025. The forward-looking statements are mostly about ongoing development programs, clinical trials, animal studies, and collaborations. There is no mention of secured orders, contracts that will bring revenue in the next year, or any specific near-term revenue ramp. The only revenue they have is from sales of rhCollagen products and the milestone payment from AbbVie. The milestone payment was already received in 2023. Future milestones are not specified and are contingent.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| EGY | VAALCO Energy, Inc. | Q2 2021 | 2021-08-12 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| KNDI | Kandi Technologies Group, Inc. | Q2 2021 | 2021-08-09 | F |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| UPLD | Upland Software, Inc. | Q4 2017 | 2018-03-08 | C+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| LEA | Lear Corporation | Q2 2017 | 2017-07-26 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
| ACCO | ACCO Brands Corporation | Q1 2016 | 2016-04-27 | B+ |
EVGO · Q2 2022 → YESThe question is about whether management's explanation of the next year's business is built primarily from specific pieces already secured or in motion, making current results understate the locked-in...YES The transcript shows management framing the next-year outlook around the newly announced, signed GM-Pilot eXtend deal (up to 2,000 stalls at 500 locations, with EVgo procuring, constructing, operating, and maintaining, delivering both near-term revenue and longer-term contracted cash flows that already exceed IRR hurdles) plus the Delta supply agreement (1,000+ chargers for 2,000 stalls through 2026) and the GSA BPA (which removes procurement friction for federal fleets). These pieces are presented as already committed and in motion, with explicit timing for revenue ramp in H2 2022 and into 202 3, while the company notes it has baked some of the PFJ contribution into its 2022 guidance. The structure treats these secured elements as the primary bridge from today’s numbers to a meaningfully larger business, rather than relying on pipeline, demand, or future bids. Other items (NEVI solicitations, fleet pilots ) are secondary and contingent, but the core forward posture is built on the named, already-executed contracts and programs. Current results visibly understate the locked-in trajectory because the eXtend model shifts cash flows forward and the secured stalls/contracts are only beginning to flow.
BRBR · Q4 2023 → YESThe question is about whether management's explanation of the next year's business is built primarily from specific pieces already secured or in motion, such that current results understate the locked...YES The transcript shows management framing fiscal '24 growth as driven by concrete, already-committed pieces: the two co-man additions from '23 that are scaling, the Michael Foods greenfield facility that starts up in December and will be a "much larger contributor" in the second half of '24, the 20 %+ production growth plan (40 % from new co-mans in '24, 40 % from lapping prior adds, 20 % from existing), and the restart of shake promotions in Q2 plus marketing step-up in Q4 once target weeks of supply are reached. These are presented as nameable, scheduled 2024 actions that will enable double-digit volume growth for both Premier Protein and Dymatize, with the current-year results (22 % sales growth under capacity constraints) treated as a base that the locked-in capacity ramp will visibly outgrow.
MEC · Q3 2022 → YESThe question is about whether management's explanation of the next year's business is built primarily from specific pieces already secured or in motion, such that current results understate the locked...YES The transcript shows management framing 2023 growth primarily around specific, already secured or in-motion pieces: the electric side-by-side family of parts (production fully launching in 2023), the reshoring project for the commercial vehicle customer (production scheduled to start early 2023), the high-value ag takeover project (already awarded), incremental business on the light-duty truck platform, and the new industrial infrastructure customer relationship (quickly supported and expected to grow). These are presented as nameable, committed items whose contributions are beginning or ramping over the coming year.